The future of Nippon Shinyaku’s Duchenne muscular dystrophy (DMD) therapy Viltepso has been thrown into doubt after it failed a clinical trial designed to upgrade its 2020 accelerated approval. The ...
The sleepless nights and steep learning curve that will be familiar to any new parent take those challenges to new levels when that parent also has a progressive muscle degeneration and weakness ...
Cardiomyopathy is the leading cause of death in boys with Duchenne muscular dystrophy (DMD). While cardiac magnetic resonance (CMR) is routinely used to assess fibrosis and left ventricular (LV) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results